![]() |
|
|
| Abstract |
|
|
|
|
Session 69
Poster Session
Immunopathogenesis Issues Addressed by Therapeutic Interventions Session Time: 4:30-6:30 pm Room 4E-F |
Methods: 13 chronically HIV-infected patients enrolled in the Swiss Spanish Intermittent Therapy Trial, participated in a substudy with frequent blood sampling. (Entry criteria: 1st potent antiretroviral treatment [ART], HIV plasma RNA < 50 copies/mL > 6 month, CD4 count > 300 /mL). Study design: 4 cycles of a 2-week ART-interruption (STI) followed by 8-10 weeks of retreatment. After week 40, ART was stopped > 3 month. Plasma viral load (VL) testing was done on day per cycle, and HIV-specific CTL responses by Results: 10 of 13 patients revealed a reduction in plateau VL after STI (mean 0.7 log) and 3 showed an increase (mean 0.5 log) (p=0.045). Up rates during viral rebound decreased as rounds increased (p=0.039) but down rates after re-initiation of ART after each STI did not change significantly. Viral dynamics predicted VL plateau after treatment stop post week 40. The average chronic basic reproductive number (cR0) was highly predictive of VL plateau. In a model relating cR0 to plateau viral load, terms describing factors that decrease viral load to below that expected from STI dynamics were significant (p=0.034). Over the 4 STI cycles total spot forming cells (SFC) increased by an average of 500 SFC per round (p=0.026) and the number of responses increased by one every other round (p=0.002). Yet, changes in SFC did not correlate with changes in VL plateau. Conclusions: Viral dynamics during STIs were predictive of plateau viral load reached post STI. However, changes in plateau VL were not explained by changes in HIV-specific CTL responses, suggesting that factors other than CTL may be responsible for reductions in viral setpoints observed after 4 rounds of STIs. |
|
©2002 9th Conference on Retroviruses and Opportunistic Infections |